Bioequivalence clinical trial of two formulations of bilastine.

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-515077-96-00

Acronym

N-BIL-24-288

Enrollment

Registered

2024-08-26

Start date

2024-09-13

Completion date

2024-10-14

Last updated

2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026